Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Journal Article

Carbone, David Paul, Morgensztern, Daniel, Le Moulec, Sylvestre, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L., Glisson, Bonnie S., Dowlati, Afshin, Rudin, Charles M., Lally, Satwant, Yalamanchili, Sreeni, Wolf, Juergen, Govindan, Ramaswamy and Besse, Benjamin (2018). Efficacy and safety of rovalpituzumab tesirine in patients With DLL3-expressing, >= 3rd line small cell lung cancer: Results from the phase 2 TRINITY study. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Morgensztern, Daniel, Besse, Benjamin, Greillier, Laurent ORCID: 0000-0002-5807-9503, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L., Glisson, Bonnie S., Farago, Anna F., Dowlati, Afshin, Rudin, Charles M., Le Moulec, Sylvestre, Lally, Satwant, Yalamanchili, Sreeni, Wolf, Juergen, Govindan, Ramaswamy and Carbone, David P. (2019). Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study. Clin. Cancer Res., 25 (23). S. 6958 - 6967. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

This list was generated on Thu Feb 25 02:07:30 2021 CET.